Management tracks: bluebird, Sangamo

Gene therapy company bluebird bio Inc. (NASDAQ:BLUE) promoted Alison Finger to chief commercial

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE